Detection of Low Numbers of Neuroblastoma Cells in Vitro

Annals of the Academy of Medicine Singapore

Volumn 26, Issue 4, 1997, Pages 415-420

  Lai, P S ^a,c   Chee, S ^a   Chiu, L L ^a   Sano, K ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KOBE UNIVERSITY   (Japan)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Disseminating; mRNA analysis; Prognosis; Residual cells; RT PCR

Indexed keywords

DNA; MESSENGER RNA; TUMOR MARKER;

ARTICLE; BLOOD; BONE MARROW CELL; CELL COUNT; CELL CULTURE; HUMAN; MOLECULAR GENETICS; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

BASE SEQUENCE; BONE MARROW CELLS; CELL COUNT; DNA, NEOPLASM; HUMANS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031174466     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Crist W M, Kun L E. Common solid tumours of childhood. N Engl J Med 1991; 324:461-71.
2. Evans A E, D'Angio G J, Propert K, Anderson J, Hann H-W. Prognostic factors in neuroblastoma. Cancer 1987; 59:1853-9.
3. Evans A E, D'Angio G J, Randolph J A. A proposed staging for children with neuroblastoma. Cancer 1971; 27:374-8.
4. Voute P A, de Kraker J, Burgers JMV. Tumours of the sympathetic nervous system. In: Voute PA, Barrett A et al, editors. Cancer in Children. New York: Springer Verlag, 1986:26-37.
5. Evans A E, Baum E, Chard R. Do infants with stage IV-S neuroblastoma needs treatment? Arch Dis Child 1981; 56:271-4.
6. Kohl N E, Kanda N, Schreck R R, Bruns G, Latt S A, Gilbert F, et al. Transposition and amplification of oncogene-related sequences in human neuroblastoma. Cell 1983; 35:359-67.
7. Brodeur G M, Seeger R C, Schwals M, Varmus H E, Bishop J M. Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage. Science 1984; 224:1121-4.
8. BrodeurGM. Neuroblastoma: Clinical significance of generic abnormalities. Cancer Surg 1990; 9:673-88.
9. Caron H, vanSluis P, vanHoeve M, deKraker J, Bras J, Slater R, et al. Allelic loss of chromosome Ip36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genet 1993; 4:187-90.
10. Taylor S R, Blatt J, Costantino J P, Roederer M, Murphy R F. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. Cancer 1988; 62:749-54.
11. Moss T J, Reynolds C P, Sather H N. Prognostic value of immunocytologic detecting of bone marrow metastases in neuroblastoma. N Engl J Med 1991; 324:219-26.
12. Henderson M J, McGinlay J M, Lewis I, Bailey C. Measurement of dopamine, HVA and HMMA in untimed urine samples: establishment of age-related reference data in children. Ann Clin Biochem 1992; 29:162-7.
13. Beck D, Maricaz O P, Gron N. Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples. Eur J Paediatr 1988; 147:609-12.
14. Rogers D W, Treleaven J G, Kemshead J T, Pritchard J. Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma. J Clin Pathol 1989; 42:422-6.
15. Yokota S, Hansen-Hagge T E, Ludwig W D, Reiter A, Raghavachar A, Kleihauer E, et al. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukaemia patients. Blood 1991; 77:331-9.
16. Fong C, Dracopoli N C, White P S, Merrill P T, Griffith R C, Housman D E, et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastoma: correlation with N-myc amplification. Proc Natl Acad Sci USA 1989; 86:3753-7.
17. Moss T J, Sanders D G, Lasky L C, Bostrom B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 1990; 76:1879-83.
18. Meyers M W, Lazzarim R A, Lee V M-Y, Schlaepfer W W, Nelson L D. The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J 1987; 6:1617-26.
19. Bergmann M, Lahr G, Mayerhofer A, Gratzl M. Expression of synaptophysin during the prenatal development of the rat spinal cord: correlation with basic differentiation process of neurons. Neuroscience 1991; 42:569-2.
20. Chomezynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
21. Leube R E, Kaiser P, Seiter A, Zimbelmann R, Franke W W, Rehm H, et al. Synaptophysin: molecular organization and mRNA expression as determined from cloned cDNA. Eur Mol Biol Org J 1987; 6:3261-8.
22. Nakajima-lijirna S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985; 82:6133-7.
23. Treleaven J G, Gibson F M, Ugelstad J, Rembaum A, Philip T, Caine G D, et al. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1984; 1:70-3.
24. Favrot M C, Herve P. Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukemias. Bone Marrow Transplant 1987; 2:117-22.
25. Sugimoto T, Sawada T, Matsumura T, Kemshead J T, Horii Y, Saida T, et al. Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies. Med Pediatr Oncol 1988; 16:190-6.
26. Matsumura T, Sugimoto T, Sawada T, Amagai T, Negoro S, Kemshead J T. Cellssurface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8). Cancer Res 1987; 47:2924-30.
27. Jakobovits A, Schwab M, Bishop J M, Martin G. Expression of N-myc in teratocarcinoma stem cell and mouse embryos. Nature 1985;318:188-91.
28. Zimmerman K A, Yancopoulos G D,Collum R G, Smith R K, Kohl N E, Denis K A, et al. Differential expression of myc-family genes during murine development. Nature 1986; 319:780-3.
29. Grady E F, Schwab M, Rosenau W. Expression of N-myc and c-src during the development of fetal human brain. Cancer Res 1987; 47:2931-6.
30. Livingstone A, Mairs R J, Russell J, O'Donoghue J, Gaze M N, Wheldon T E. N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatment. Eur J Cancer 1994; 30A:382-9.
31. Mattano L A, Moss T J, Emerson S G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992; 52:4701-5.
32. Naito H, Kuzumaki N, Uchino J, Kobayashi R, Shikawo T, Ishikawa Y, et al. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 1991; 27:762-5.
33. Burchill S A, Bradbury F M, Smith B, Lewis II, Selby P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer 1994; 57:671-4.